Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Biotech Newspaper
26. Februar 2019 08:00 ET
|
Q BioMed Inc.
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. (QBIO), a biotechnology acceleration company, today announced that in the February issue of DDNews, journalists conducted an interview with...
Interviews with CEO Denis Corin of Q BioMed and CEO George Nikopoulos of Mannin Research
22. Februar 2019 08:02 ET
|
Q BioMed Inc.
NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announces multiple interviews with the company’s CEO, Denis Corin, and the Q BioMed...